GHRP-2 and Tesamorelin Interaction

Synergistic
Mechanism-based 55% confidence

GHRP-2 and Tesamorelin have a synergistic interaction with 55% confidence. GHRP-2 and Tesamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

GHRP-2

Growth Hormone Releasing Peptide-2 | Pralmorelin

GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.

Half-life: ~30 minutes Typical dose: 100-300 mcg growth hormone, weight loss
ghrelin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (GHRP-2, Tesamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (GHRP-2, Tesamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (GHRP-2, Tesamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take GHRP-2 with Tesamorelin?

Yes, GHRP-2 and Tesamorelin can generally be taken together. GHRP-2 and Tesamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone.

Is GHRP-2 and Tesamorelin safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between GHRP-2 and Tesamorelin?

GHRP-2 and Tesamorelin amplify GH release through complementary mechanisms (GHRH primes, GHRP triggers). This is a well-established synergistic combination — expect significantly greater GH output than either alone. This assessment has 55% confidence and is inferred from pharmacological mechanism analysis.

How should I time GHRP-2 and Tesamorelin?

GHRP-2 has a half-life of ~30 minutes and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: GHRP-2 vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.